Methenamine Prophylaxis Reduces Recurrent Urinary Tract Infections

Files

Authors

Salwan Al Hani, Oakland University, William Beaumont School of Medicine Medical Student
Matthew Sims, Corewell Health East

Description

• Recurrent urinary tract infections (UTIs) are the most common outpatient infection in the US and are often managed with antibiotics in clinical practice.
• A recurrent UTI is defined as 2 or UTIs each 6 months or 3 or more UTIs each year.
• Methenamine is an antiseptic compound approved by the FDA to prevent rUTIs but is seldom used in clinical practice.
• Under acidic conditions, methenamine is converted to 6 molecules of formaldehyde, a compound which prevents bacterial growth.
• This study seeks to determine the effectiveness of methenamine for prevention of recurrent UTIs.

Publication Date

5-2024

Keywords

urinary tract infections

Disciplines

Infectious Disease

Recommended Citation

Hani SA, Sims M. Methenamine prophylaxis reduces recurrent urinary tract infections. Poster presented at: Oakland University William Beaumont School of Medicine Embark Capstone Colloquium; 2024 May; Rochester Hills, MI.

Comments

The Embark Capstone Colloquium at the Oakland University William Beaumont School of Medicine, Rochester Hills, MI, May, 2024.